More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Conventional markers used for diagnosing and managing diabetes have recently come to question. This blog addresses some of ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Signs an Amended & Restated License Agreement for Multiple Technologies for Gene Therapy for Type 1 and Type 2 Diabetes Forms a Wholl ...

It is the world's first tubeless insulin delivery system ... closest to a complete artificial pancreas, however, are those that also administer glucagon. Beta Bionics' iLet has shown promise ...

The company also reported it is continuing work on an AID system that would, in addition to using insulin to lower blood sugar, also contain glucagon to raise blood ... manufacturer of the iLet Bionic ...

An artificial pancreas combines a glucose monitor with an insulin pump. In this video, Griffin Rodgers, MD, director of ...